Cargando…

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial

Treating Veterans with chronic obstructive pulmonary disease complicated by pulmonary hypertension (COPD‐PH) using phosphodiesterase type‐5 inhibitor pharmacotherapy is common, but efficacy data are lacking. To address this further, patients with COPD‐PH from five Department of Veterans Affairs hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maron, Bradley A., Choudhary, Gaurav, Goldstein, Rebekah L., Garshick, Eric, Jankowich, Matthew, Tucker, Troo J. S., LaCerda, Kathleen A., Hattler, Brack, Dempsey, Edward C., Sadikot, Ruxana T., Shapiro, Shelley, Rounds, Sharon I., Goldstein, Ronald H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053004/ https://www.ncbi.nlm.nih.gov/pubmed/35506072 http://dx.doi.org/10.1002/pul2.12043

Ejemplares similares

Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities
por: Steiner, Johannes, et al.
Publicado: (2015)

Idiopathic pulmonary artery dissection: a case report
por: Mohammad, Khalid, et al.
Publicado: (2009)

Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta‐Analysis
por: Kolte, Dhaval, et al.
Publicado: (2018)

Prevalence and Clinical Characteristics Associated with Pulmonary Hypertension in African-Americans
por: Choudhary, Gaurav, et al.
Publicado: (2013)

Multispecialty pulmonary hypertension clinic in the VA
por: Jankowich, Matthew, et al.
Publicado: (2017)

Relationship of Iron Deficiency and Serum Ferritin Levels with Pulmonary Hypertension: The Jackson Heart Study
por: Jankowich, Matthew, et al.
Publicado: (2016)

Peptide Nanomedicines for Treatment of Acute Lung Injury
por: Sadikot, Ruxana T.
Publicado: (2012)

Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database
por: Ventetuolo, Corey E., et al.
Publicado: (2017)

Use of Tadalafil for Treating Pulmonary Arterial Hypertension Secondary to Chronic Obstructive Pulmonary Disease
por: Kim, Hyun-Sook, et al.
Publicado: (2007)

A Case of Acute Pulmonary Thromboembolism after Taking Tadalafil
por: Lee, Jinwoo, et al.
Publicado: (2012)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart Study
por: Lakshmanan, Suvasini, et al.
Publicado: (2020)

Gender Differences in Risk Factors Associated With Pulmonary Artery Systolic Pressure, Heart Failure, and Mortality in Blacks: Jackson Heart Study
por: Lakshmanan, Suvasini, et al.
Publicado: (2020)

PGD Synthase and PGD(2) in Immune Resposne
por: Joo, Myungsoo, et al.
Publicado: (2012)

Bacterial Infections Associated with Immunosuppressive Agents Commonly Used in Patients with Interstitial Lung Diseases
por: Chaaban, Said, et al.
Publicado: (2023)

Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
por: Katz, Stuart D.
Publicado: (2007)

Tadalafil Nanoemulsion Mists for Treatment of Pediatric Pulmonary Hypertension via Nebulization
por: Elbardisy, Bassant, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Bacterial Infections
por: Maurice, Nicholas M., et al.
Publicado: (2023)

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
por: Falk, Jeremy A, et al.
Publicado: (2010)

Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review
por: Henrie, Adam M, et al.
Publicado: (2015)

Long-term improvement during tadalafil therapy in a patient with pulmonary hypertension secondary to pulmonary Langerhans cell histiocytosis
por: Nemoto, Kenji, et al.
Publicado: (2016)

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease
por: Gillmeyer, Kari R., et al.
Publicado: (2021)

Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
por: Gillmeyer, Kari R., et al.
Publicado: (2022)

Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy
por: Abston, Eric, et al.
Publicado: (2020)

Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats
por: Mamazhakypov, Argen, et al.
Publicado: (2020)

THE DIFFERING SURVIVAL OF NORMAL AND SENSITIZED SPLEEN CELLS TRANSFERRED TO ALLOGENEIC HOSTS
por: Hattler, Brack G., et al.
Publicado: (1964)

Respiratory dialysis: a new therapy for chronic obstructive pulmonary disease
por: Morley, S, et al.
Publicado: (2008)

Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model
por: Ferguson-Sells, Lisa, et al.
Publicado: (2021)

Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension
por: Rehmel, Jessica, et al.
Publicado: (2021)

Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
por: Sadikot, Ruxana T., et al.
Publicado: (2017)

Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending‐dose study
por: Small, David, et al.
Publicado: (2019)

Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience
por: Youssef, David Edward, et al.
Publicado: (2023)

Pain in Veterans with COPD: relationship with physical activity and exercise capacity
por: Raphaely, Rebecca A., et al.
Publicado: (2021)

The Role of Lipids Mediators in Inflammation and Resolution
por: Rogerio, Alexandre de Paula, et al.
Publicado: (2015)

Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects
por: Mirsaeidi, Mehdi, et al.
Publicado: (2015)

Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population
por: Chaaban, Said, et al.
Publicado: (2023)

Tadalafil in the treatment of erectile dysfunction
por: Coward, Robert M, et al.
Publicado: (2008)

Myopathy with Concurrent Tadalafil and Simvastatin
por: Gargante, Maria Pia, et al.
Publicado: (2009)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
por: Johnson, Shelsey W., et al.
Publicado: (2022)

FEV(1) and FVC and systemic inflammation in a spinal cord injury cohort
por: Hart, Jaime E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mlqchdgt3r9nfi6ssq0dln5e5d